Publisher's Synopsis
The pharmaceutical industry is one of the most closely regualted sectors of the Western economies. In this book, Leigh Hancher analyzes the regulatory systems in France and the UK, with particular emphasis on safety, control of price and profit, and promotional restrictions. She examines in detail the laws on competition and intellectual property as they affect the industry and traces the impact of European law and policy on these different regulatory controls, describing the manner in which national legislators and policy-makers are constrained by EC law.;Dr Hancher offers an analysis of regulation as a dynamic process. She explores its impact on the operating environment of major research-based firms and compares the ways in which different legal cultures may provide different opportunities or impose different forms of constraint on policy makers. Her study gives a comprehensive overview of the laws governing competition and intellectual property in France and the UK.
